The government is aiming to increase the share of generic drugs used in medical treatment from the current 50 percent to 80 percent. It hopes this move will help slow the growth of the nation’s total medical expenses. But in pursuing the policy, the government must ensure the safety and stable supply of generic drugs.

The merit of generic drugs is that they’re 30 to 50 percent cheaper than non-generic drugs because they’re based on expired patents of brand name drugs so expenditures on research and safety tests are not required.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.